Product Information
ALLERGY RLF (CETRZN) 10 MG TAB is a generic product labeled by Time-Cap Labs Inc., priced at $0.0613 per EA under NDC 49483069250. Its NADAC has been published 211 times since Sep 21, 2022.
FDA first approved this application on Jun 15, 2010.
Strength
10 mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483069250
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078933FDA Approved
6/15/2010
On Market Since
2/12/2022
Pharmacological Classes
Price Statistics
The NADAC for ALLERGY RLF (CETRZN) 10 MG TAB has been published 211 times since Sep 21, 2022, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0613 per EA |
|---|---|
| All-time high | $0.0721 (Dec 10, 2025) |
| All-time low | $0.0539 (Jul 17, 2024) |
| 52-week high | $0.0721 |
| 52-week low | $0.0611 |
| Median price | $0.0653 |
| Average price | $0.0649 |
| Largest weekly change | +24.2% (Aug 21, 2024) |
| Weeks tracked | 211 |
| Tracking since | Sep 21, 2022 |
Generic Alternatives
The matcher finds 15 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Time-Cap Labs Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALLERGY RLF (CETRZN) 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALLERGY RLF (CETRZN) 10 MG TAB, manufactured by Time-Cap Labs Inc., is $0.0613 per EA (NDC 49483069250), effective Sep 30, 2026.
How has the price of ALLERGY RLF (CETRZN) 10 MG TAB changed over time?
Over the history we have for it, the NADAC for ALLERGY RLF (CETRZN) 10 MG TAB has declined 12.8%. It has been tracked across 211 weekly CMS publications since Sep 21, 2022.
What are the highest and lowest recorded NADAC prices for ALLERGY RLF (CETRZN) 10 MG TAB?
Since Sep 21, 2022, the NADAC for ALLERGY RLF (CETRZN) 10 MG TAB has ranged from a low of $0.0539 (Jul 17, 2024) to a high of $0.0721 (Dec 10, 2025), with a median of $0.0653 per EA.
Are there cheaper alternatives to ALLERGY RLF (CETRZN) 10 MG TAB?
15 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALLERGY RLF (CETRZN) 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ALLERGY RLF (CETRZN) 10 MG TAB?
ALLERGY RLF (CETRZN) 10 MG TAB (NDC 49483069250) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.